The many roles for fluorine in medicinal chemistry

被引:3148
作者
Hagmann, William K. [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
D O I
10.1021/jm800219f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One cannot overestimate the profound influence that organofluorine chemistry has had on drug discovery. The ever increasing array of commercially available fluorinated starting materials coupled with novel and imaginative synthetic methodologies offers to the medicinal chemist broad opportunities to positively influence the direction and timelines in a drug discovery program. Medicinal chemists should approach the various structure-activity relationships that may need to be addressed with a keen understanding of the potential that selective fluorination may afford. That potential may be realized in solving issues as different as changes in solubility, CNS penetration, metabolic stability, or improvements in potency. A greater appreciation of the role(s) that fluorine substitution can have on the physicochemical properties in a molecule gives the medicinal chemist more strategies to solve some of their challenges in a drug discovery program. Hopefully, this Perspective and the few cited examples will provide incentives to further explore the opportunities in organofluorine chemistry as it relates to medicinal chemistry and drug discovery. © 2008 American Chemical Society.
引用
收藏
页码:4359 / 4369
页数:11
相关论文
共 83 条
[1]   The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake [J].
Addy, Carol ;
Wright, Hamish ;
Van Laere, Koen ;
Gantz, Ira ;
Erondu, Ngozi ;
Musser, Bret J. ;
Lu, Kaifeng ;
Yuan, Jinyu ;
Sanabria-Bohorquez, Sandra M. ;
Stoch, Aubrey ;
Stevens, Cathy ;
Fong, Tung M. ;
De Lepeleire, Inge ;
Cilissen, Caroline ;
Cote, Josee ;
Rosko, Kim ;
Gendrano, Isaias N., III ;
Nguyen, Allison Martin ;
Gumbiner, Barry ;
Rothenberg, Paul ;
de Hoon, Jan ;
Bormans, Guy ;
Depre, Marleen ;
Eng, Wai-Si ;
Ravussin, Eric ;
Klein, Samuel ;
Blundell, John ;
Herman, Gary A. ;
Burns, H. Donald ;
Hargreaves, Richard J. ;
Wagner, John ;
Gottesdiener, Keith ;
Amatruda, John M. ;
Heymsfield, Steven B. .
CELL METABOLISM, 2008, 7 (01) :68-78
[2]   Enantioselective organocatalytic α-fluorination of aldehydes [J].
Beeson, TD ;
MacMillan, DWC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (24) :8826-8828
[3]   Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K [J].
Black, WC ;
Bayly, CI ;
Davis, DE ;
Desmarais, S ;
Falgueyret, JP ;
Léger, S ;
Li, CS ;
Massé, F ;
McKay, DJ ;
Palmer, JT ;
Percival, MD ;
Robichaud, J ;
Tsou, N ;
Zamboni, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) :4741-4744
[4]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[5]   VAN DER WAALS VOLUMES + RADII [J].
BONDI, A .
JOURNAL OF PHYSICAL CHEMISTRY, 1964, 68 (03) :441-+
[6]  
Borodine A, 1863, LIEBIGS ANN CHEM, V126, P58
[7]  
BROWN HC, 1955, DETERMINATION ORGANI
[8]   Design, synthesis, and evaluation of a novel class of enantioselective electrophilic fluorinating agents:: N-fluoro ammonium salts of cinchona alkaloids (F-CA-BF4) [J].
Cahard, D ;
Audouard, C ;
Plaquevent, JC ;
Roques, N .
ORGANIC LETTERS, 2000, 2 (23) :3699-3701
[9]   Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors [J].
Caldwell, CG ;
Chen, P ;
He, JF ;
Parmee, ER ;
Leiting, B ;
Marsilio, F ;
Patel, RA ;
Wu, JK ;
Eiermann, GJ ;
Petrov, A ;
He, HB ;
Lyons, KA ;
Thornberry, NA ;
Weber, AE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) :1265-1268
[10]   EFFICIENT UTILIZATION OF TETRABUTYLAMMONIUM BIFLUORIDE IN HALOFLUORINATION REACTIONS [J].
CAMPS, F ;
CHAMORRO, E ;
GASOL, V ;
GUERRERO, A .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (18) :4294-4298